Evidence map›Paper›PMID 33860181›Full record

ArticleACS pharmacology & translational science2021

EEG Gamma Band Alterations and REM-like Traits Underpin the Acute Effect of the Atypical Psychedelic Ibogaine in the Rat.

Joaquín González, Matias Cavelli, Santiago Castro-Zaballa, Alejandra Mondino, Adriano B L Tort, Nicolás Rubido, Ignacio Carrera, Pablo Torterolo

Open access · greenAbstract read
In one paragraph

Article in ACS pharmacology & translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. 5-HTInternational journal of molecular sciences · 2024
    Article
  9. Review
  10. Ketamine and sleep modulate neural complexity dynamics in cats.The European journal of neuroscience · 2022
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Joaquín GonzálezDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, 11200, Uruguay.
Matias CavelliDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, 11200, Uruguay.
Santiago Castro-ZaballaDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, 11200, Uruguay.
Alejandra MondinoDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, 11200, Uruguay.
Adriano B L TortBrain Institute, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte 59056, Brazil.
Nicolás RubidoAberdeen Biomedical Imaging Centre, University of Aberdeen, Aberdeen AB25 2ZG, United Kingdom.
Ignacio CarreraDepartamento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
Pablo TorteroloDepartamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, 11200, Uruguay.
Universidad de la República de Uruguay · UYUniversidade Federal do Rio Grande do Norte · BRUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ibogaine is a psychedelic alkaloid that has attracted large scientific interest because of its antiaddictive properties in observational studies in humans as well as in animal models. Its subjective effect has been described as intense, vivid dream-like experiences occurring while awake; hence, ibogaine is often referred to as an oneirogenic psychedelic. While this unique dream-like profile has been hypothesized to aid the antiaddictive effects, the electrophysiological signatures of this psychedelic state remain unknown. We previously showed in rats that ibogaine promotes a waking state with abnormal motor behavior along with a decrease in NREM and REM sleep. Here, we performed an in-depth analysis of the intracranial electroencephalogram during "ibogaine wakefulness". We found that ibogaine induces gamma oscillations that, despite having larger power than control levels, are less coherent and less complex. Further analysis revealed that this profile of gamma activity compares to that of natural REM sleep. Thus, our results provide novel biological evidence for the association between the psychedelic state and REM sleep, contributing to the understanding of the brain mechanisms associated with the oneirogenic psychedelic effect of ibogaine.

Identifiers

PMID33860181
PMCPMC8033602
OpenAlexW3119374612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.